Sutro Biopharma (STRO) CEO pay vs performance, through FY2025
$STRO · SUTRO BIOPHARMA, INC.Data through FY2025 — latest proxy filed 2026-04-22, checked for new filings 2026-08-21. Every number links to its source.
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2021 | Same, peer group since FY2021 | Net income |
|---|---|---|---|---|---|---|
| 2025 | — | — | — | $14.00 | — | -$191.0M |
| 2024 | $2.3M | $925,006 | $558,592 | $12.00 | — | -$227.0M |
| 2023 | $2.1M | -$539,427 | $1.9M | $20.00 | — | -$107.0M |
| 2022 | $3.0M | -$307,003 | $93,104 | $37.00 | — | -$119.0M |
| 2021 | $5.6M | $1.6M | $1.6M | $69.00 | — | -$106.0M |
Frequently asked
How much did the STRO CEO make in 2025?
— in Compensation Actually Paid (CAP) as SUTRO BIOPHARMA, INC.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-22.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on STRO: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary